Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

STRATA Skin Sciences (SSKN) Change in Cash (2016 - 2025)

STRATA Skin Sciences (SSKN) has disclosed Change in Cash for 14 consecutive years, with $836000.0 as the latest value for Q4 2025.

  • Quarterly Change in Cash rose 320.1% to $836000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$683000.0 through Dec 2025, down 243.19% year-over-year, with the annual reading at -$683000.0 for FY2025, 243.19% down from the prior year.
  • Change in Cash hit $836000.0 in Q4 2025 for STRATA Skin Sciences, down from $1.1 million in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $6.2 million in Q2 2023 to a low of -$4.0 million in Q3 2021.
  • Historically, Change in Cash has averaged -$510000.0 across 5 years, with a median of -$668000.0 in 2021.
  • Biggest five-year swings in Change in Cash: tumbled 29450.0% in 2021 and later skyrocketed 800.0% in 2023.
  • Year by year, Change in Cash stood at -$461000.0 in 2021, then crashed by 338.18% to -$2.0 million in 2022, then skyrocketed by 82.82% to -$347000.0 in 2023, then skyrocketed by 157.35% to $199000.0 in 2024, then surged by 320.1% to $836000.0 in 2025.
  • Business Quant data shows Change in Cash for SSKN at $836000.0 in Q4 2025, $1.1 million in Q3 2025, and -$1.9 million in Q2 2025.